Skip to content

EV / EBITDA at other companies

Eli Lilly logo
Eli LillyLLY
25.9×-24.4×
Hims & Hers Health logo
Hims & Hers HealthHIMS
124.2×+76.2×
The Beachbody Company logo
The Beachbody CompanyBODI
3.2×
Herbalife logo
HerbalifeHLF
5.3×0.0×
Lifevantage Corporation logo
Lifevantage CorporationLFVN
5.6×-5.1×

Other financials

Income statement

See full
Revenue$168.3M-9.8%
Gross profit$118.7M-10.7%
Operating income-$30.4M-50.7%
Net income-$52.0M+28.4%
EPS (diluted)-$5.20-471%

Balance sheet

See full
Cash & equivalents$120.9M-48.9%
Total debt$468.2M-71.7%
Total equity$265.6M+122%
Total assets$881.1M+26.4%

Cash flow

See full
Operating cash flow-$33.5M-324%
CapEx$6.0K
Free cash flow$8.4M

Valuation

See full
Market cap$159.78M-95.6%
Enterprise value$507.1M-87.2%
P/S0.3×+0.2×

Profitability

See full
Gross margin71%+5.5pp
Operating margin-34.5%-37.5pp
Net margin-23.2%-8.6pp
FCF margin-0.7%-3.3pp

Returns & leverage

See full
Return on equity268.4%
Debt / equity1.8×
Current ratio1.2×+1.0×

Where this comes from

Calculated from WW International, Inc.’s reported figures.

Based on the most recent quarter.

The official record: WW International, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about WW International, Inc.'s ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is WW International, Inc.'s EV / EBITDA?
WW International, Inc. (WW) reported EV / EBITDA of 31.3× in Q1 2026.
How has WW International, Inc.'s EV / EBITDA changed year-over-year?
WW International, Inc.'s EV / EBITDA decreased by 18.4% year-over-year, from 38.4× to 31.3×.
What is the long-term trend for WW International, Inc.'s EV / EBITDA?
Over 3 years (2020 to 2025), WW International, Inc.'s EV / EBITDA has grown at a 80.1% compound annual growth rate (CAGR), from 15.2× to 89×.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.